Macquarie Group
BEAT

Macquarie Group’s BioTelemetry, Inc. BEAT Stock Holding History

Macquarie Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,657
Closed -$119K – 2521
2020
Q4 		$119K Hold
1,657
– – ﹤0.01% 1828
2020
Q3 		$76K Hold
1,657
– – ﹤0.01% 1852
2020
Q2 		$75K Buy
+1,657
New +$74.2K ﹤0.01% 1834
2019
Q2 		– Sell
-761,048
Closed -$47.7M – 1916
2019
Q1 		$47.7M Sell
761,048
-214,535
-22% -$14.7M 0.08% 263
2018
Q4 		$58.3M Sell
975,583
-276,100
-22% -$16.6M 0.11% 176
2018
Q3 		$80.7M Sell
1,251,683
-28,323
-2% -$1.58M 0.13% 143
2018
Q2 		$57.6M Buy
1,280,006
+19,749
+2% +$787K 0.1% 201
2018
Q1 		$39.1M Buy
1,260,257
+503,994
+67% +$16.6M 0.07% 290
2017
Q4 		$22.6M Buy
756,263
+747,829
+8,867% +$21.7M 0.04% 447
2017
Q3 		$279K Buy
+8,434
New +$292K ﹤0.01% 1641

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.69B AUM 46.33% 1-Year Est. Return

Macquarie Group's BEAT Position: Q1 2021 in Review

Macquarie Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 1,657 shares — an estimated $119K sold.

Macquarie Group first reported a position in BEAT in Q3 2017 and held it in 10 quarters. The position peaked at $80.7M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Macquarie Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Macquarie Group sold 1,657 BioTelemetry, Inc. shares in Q1 2021, an estimated $119K.
  • Macquarie Group first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 10 quarters.
  • Macquarie Group's BioTelemetry, Inc. position peaked at $80.7M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Macquarie Group's 13F filing for Q1 2021, filed 14 May 2021.